Somatic Symptom Disorder Clinical Trial
Official title:
Effects of a Pandemic Forced Isolation Context on Adolescents With Somatic Symptom Disorder. A Panel Study
NCT number | NCT05795803 |
Other study ID # | RC 11/2020 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | April 1, 2020 |
Est. completion date | May 31, 2020 |
Verified date | March 2023 |
Source | IRCCS Burlo Garofolo |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is to evaluate whether a forced isolation context (such provided by the ongoing Covid-19 pandemic restrictive measures) could reduce the burden of somatic symptoms among a group of patients with Somatic Symptom Disorder (SSD). Secondary objective is to assess if a reduction in terms of depression tendency and anxiety occurs in this specific population and which are the effect of such a context among a group of adolescents without SSD. We want to compare these results with data obtained at the end of the pandemic.
Status | Completed |
Enrollment | 115 |
Est. completion date | May 31, 2020 |
Est. primary completion date | May 31, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 12 Years to 17 Years |
Eligibility | Inclusion Criteria: - Adolescents aged between 12 and 17 years old who received a diagnosis of SSD within the last six months or before unless assessed and confirmed by a specialist within the last six months - Adolescents without a diagnosis of SSD, who previously accessed the Institute for maternal and child health "Burlo Garofolo" Emergency Department for traumatic injuries or the Pediatric Clinic/Day Hospital Service for oral immunotherapy because of food allergies. - Adolescents experiencing a quarantine period during the Covid19 pandemic. Exclusion Criteria: - Adolescents with cognitive impairment. - Adolescents with chronic diseases. - Adolescents with other neuropsychiatric disorders according to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorder (DSM V). - For the group without SSD diagnosis, any access to Emergency Department for unexplained chronic pain or any history of other psychiatric comorbidities. |
Country | Name | City | State |
---|---|---|---|
Italy | Institute for Maternal and Child Health - IRCCS Burlo Garofolo- | Trieste |
Lead Sponsor | Collaborator |
---|---|
IRCCS Burlo Garofolo |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Difference in mean PhQ15 scale scores between T0 and T1 in the SSD adolescents group. | To SSD group, the Health Questionnaire Physical Symptoms (PhQ15) will be administrated to quantify the somatic symptom burden. | During the pandemic and within 6 months after the end | |
Secondary | Difference in mean MASC2 scores between T0 and T1 in the SSD group. | SSD adolescents will receive the Multidimensional Anxiety Scale for Children (MASC 2), composed by 50 items, to quantify adolescents' anxiety. | During the pandemic and within 6 months after the end | |
Secondary | Difference in mean CDI-2 short questionnaire scores between T0 and T1 in the SSD group. | SSD adolescents will receive the Children's Depression Inventory (CDI-2) self-report short questionnaire, composed by 12 items, to quantify adolescents' depression. | During the pandemic and within 6 months after the end | |
Secondary | Difference in mean MASC2 scores between T0 and T1 in the adolescents group without SSD diagnosis. | Adolescents without SSD will receive the Multidimensional Anxiety Scale for Children (MASC 2), composed by 50 items, to quantify adolescents' anxiety | During the pandemic and within 6 months after the end | |
Secondary | Difference in mean CDI-2 short questionnaires scores between T0 and T1 in the adolescents group without SSD diagnosis. | Adolescents without SSD will receive the Children's Depression Inventory (CDI-2) self-report short questionnaire, composed by 12 items, to quantify adolescents' depression | During the pandemic and within 6 months after the end | |
Secondary | Comparison between the two groups of adolescents in the mean T1-T0 differences for MASC2 scores. | Differences in the Multidimensional Anxiety Scale for Children (MASC 2), composed by 50 items | During the pandemic and within 6 months after the end | |
Secondary | Comparison between the two groups of adolescents in the mean T1-T0 differences for CDI-2 short questionnaires scores. | Differences in Children's Depression Inventory (CDI-2) self-report short questionnaire, composed by 12 items | During the pandemic and within 6 months after the end | |
Secondary | Description of adolescents' coping strategies during a pandemic isolation context among SSD and non-SSD adolescent | A general anonymous semi-structured survey will be administered to both the groups in order to investigate their habits, social media and videogames pattern of usage, and other leisure pattern of frequency. This will provide us a description of adolescents' general coping strategies during quarantine period. | During the pandemic |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05446766 -
Feasibility Evaluation of a Self-guided Exposure-based Digital Intervention for Health Anxiety
|
N/A | |
Completed |
NCT04122846 -
Internet-based Emotional Awareness and Expression Therapy for Somatic Symptom Disorder
|
N/A | |
Completed |
NCT04511286 -
Exposure-Based Treatment for Undifferentiated Somatic Symptom Disorder
|
N/A | |
Active, not recruiting |
NCT06149182 -
Does the First Interview Matter: A Comparing Life Stress Interview Versus a Standard Psychiatric Intake Interview for Patients With Functional Somatic Disorder
|
N/A | |
Completed |
NCT04664387 -
Somatic Symptom Disorders in Patients With Myocardial Bridge
|
||
Completed |
NCT04044469 -
Reappraisal Of Medical Assurance (ROMA): An Experimental Study in Patients With Functional Somatic Symptoms
|
N/A | |
Completed |
NCT01966705 -
Cognitive Behavior Therapy for Health Anxiety: A Comparison of Three Forms of Self-help
|
N/A | |
Enrolling by invitation |
NCT03789084 -
Hybrid Trial of Brief Cognitive-Behavioral Therapy for Health Anxiety in Primary Care
|
N/A | |
Recruiting |
NCT05666921 -
Alexithymia and Attachment Style in Patients With Somatic Symptoms
|
||
Recruiting |
NCT04835103 -
Build a Research Clinic for Somatoform Patients
|
N/A | |
Completed |
NCT03986125 -
Student Anxiety & Stress Study
|
N/A | |
Recruiting |
NCT05946512 -
MR-spectroscopy in Post-covid Condition Prior to and Following a Yoga Breathing Intervention
|
N/A | |
Recruiting |
NCT05792930 -
Developing an Integrated Psychotherapy With Cognitive-behavioral Therapy and Biofeedback Therapy for Somatic Symptom Disorder
|
N/A | |
Recruiting |
NCT04899687 -
Study of Dextromethorphan in OCD and Related Disorders
|
Phase 2 | |
Completed |
NCT05886361 -
Somatic Symptoms in Autism Spectrum Disorder: Data Integration
|
||
Completed |
NCT02131883 -
Outcome of Cognitive Behavioral Therapy for Patients With Severe Health Anxiety Treated in Group Only. A RCT.
|
N/A | |
Completed |
NCT04751825 -
Internet-based Emotional Awareness and Expression Therapy for Somatic Symptom Disorder - A Randomized Controlled Trial
|
N/A | |
Completed |
NCT02314065 -
Cognitive Behavioral Therapy for Health Anxiety: Internet Treatment Versus Face-to-Face Therapy
|
N/A | |
Recruiting |
NCT06301360 -
Internet Based Emotional Awareness and Expression Therapy for Functional Somatic Disorder With and Without Therapist Support
|
N/A | |
Recruiting |
NCT05161819 -
Use Repetitive Transcranial Magnetic Stimulation to Treat Somatic Symptom Disorder
|
N/A |